What is Imprivata?
Imprivata is a premier provider of cybersecurity and digital identity software, specifically engineered for mission-critical environments. By delivering robust access management solutions, the company addresses the unique security challenges faced by healthcare institutions, government agencies, and large-scale enterprise businesses. Its platform is designed to streamline workflows for clinicians and employees while simultaneously fortifying security controls across devices, applications, and sensitive data repositories. Through its focus on user experience and operational efficiency, Imprivata has established itself as a critical partner for organizations that cannot afford downtime or security vulnerabilities.
How much funding has Imprivata raised?
Imprivata has raised a total of $881.9M across 7 funding rounds:
Series A
$13.5M
Series B
$8.9M
Other Financing Round
$12M
Unspecified
$12.5M
Series C
$15M
Stock Offering
$75M
Debt
$745M
Series A (2002): $13.5M with participation from Polaris Partners, Highland Capital Partners, and General Catalyst Partners
Series B (2006): $8.9M led by Polaris Partners, General Catalyst Partners, and Highland Capital Partners
Other Financing Round (2006): $12M supported by General Catalyst and Highland Capital Partners
Unspecified (2007): $12.5M featuring General Catalyst Partners, Highland Capital Partners, and Polaris Partners
Series C (2008): $15M backed by Polaris Partners, Highland Capital Partners, General Catalyst Partners, and Sapphire Ventures
Stock Issuance/Offering (2014): $75M, investors not publicly disclosed
Debt (2020): $745M led by Golub and Goldman Sachs
Key Investors in Imprivata
General Catalyst Partners
A venture capital firm focused on identifying and supporting transformational business opportunities across multiple sectors, providing strategic capital and operational expertise to help companies scale.
Highland Capital Partners
A venture capital firm with a significant track record in supporting innovative startups, managing substantial assets to foster long-term growth and market leadership.
Polaris Partners
A venture capital firm specializing in backing transformational companies within the biotech and healthcare sectors, offering deep industry expertise and strategic guidance.
What's next for Imprivata?
With the support of its latest capital infusion, Imprivata is well-positioned to accelerate its product roadmap and deepen its penetration into global markets. The company's strategic focus will likely remain on enhancing its privileged access management capabilities and expanding its reach within the public sector. By leveraging its established reputation and the backing of top-tier financial partners, Imprivata is poised to navigate the evolving threat landscape, ensuring that its identity-centric security model continues to meet the rigorous demands of modern, highly regulated digital ecosystems.
See full Imprivata company page
